Immunitor Completes Phase IIb imm01 Trial Enrollment and Plans Further Trials of V5 VANCOUVER, British Columbia, Nov. 14, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that its potential acquisition, Immunitor USA Inc., has announced the completion of...

Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next Week VANCOUVER, British Columbia, Nov. 1, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), a company in the business of discovery and development of immune-based therapies, today announced...

SafeShot Technologies Files Patents on New Low-Dose Version of Its Revolutionary Safety Injection Technology Called "Epiphany Ultra" MISSION VIEJO, CA--(Marketwire - September 14, 2010) -  SafeShot Technologies, LLC, a leader in safety syringe innovation, today announced the successful development and patent filings on a new...

IMSCO Issues License for Detection and Removal of Viral and Bacterial Contaminants in Blood and Blood Products NEW YORK, Aug. 26, 1999 (PRIMEZONE) -- IMSCO has issued a license for its unique proprietary electrostatic separation technology to BIOELECTRIC SEPARATION, INC., (BSI) a New York Corporation and...